Similarly, Otsuka et al.[56] reported the presence of a KRAS mutation in metastatic sites but not the primary colorectal tumor in 1 of 9 patients studied; BRAF mutation status was concordant in all cases, in contrast to what we observed. Here, KRAS is linked to colorectal neoplasm.